CASI Pharma (CASI) Reports Q4 Loss of $0.05/Share
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Join SI Premium – FREE
CASI Pharma (NASDAQ: CASI) reported Q4 EPS of ($0.05), versus ($0.05) reported last year.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
